Deal Offers Signals about the Future of Digital Pathology

By Janette Wider | From the Volume XXXII, No. 13 – September 15, 2025 Issue

THE DIGITAL PATHOLOGY MARKET IS AT AN INFLECTION POINT, AND TEMPUS’ RECENT $81.25 MILLION ACQUISITION OF PAIGE underscores both the challenges and opportunities ahead. While the pandemic temporarily accelerated digital pathology adoption, with vendors raising large su…

Read More

---

Profitable Collaboration with Pharma Companies

By Stephen Beale | From the Volume XXXII, No. 12 – August 25, 2025 Issue

CEO SUMMARY: Drug discovery efforts by pharmaceutical companies often need a boost from anatomic pathology practices and clinical laboratories. Forward-thinking lab leaders and pathologists can take advantage of their data and expertise to partner with pharma, setting the …

Read More

---

Workers Use AI More than Lab Leaders Think

By Scott Wallask | From the Volume XXXII, No. 9 – June 23, 2025 Issue

CEO SUMMARY: In part one of an analysis about the state of AI in clinical laboratories, The Dark Report explores how frontline workers, especially younger ones, are using AI tools like ChatGPT far more than lab leaders. Recent reports elsewhere in the business world show e…

Read More

---

State of Whole Genome Sequencing of Newborns

By Robert Michel | From the Volume XXXI, No. 14 – October 14, 2024 Issue

CEO SUMMARY: Genetic medicine continues to support advances in precision medicine (or personalized medicine, if you prefer). This is true in pediatrics, where several statewide pilot programs—each involving tens of thousands of newborns—are publishing studies that demonstrate how exom…

Read More

---

Major Events on Horizon to Reshape Lab Market

By Robert Michel | From the Volume XXX, No. 7 – May 8, 2023 Issue

CEO SUMMARY: Speakers at last month’s Executive War College discussed a range of significant trends and changes happening today in the U.S. healthcare system. Two of the most important trends are …

Read More

---

Pharmacogenetic Tests Deliver for Avera Health Lab

By Scott Wallask | From the Volume XXX, No. 6 – April 17, 2023 Issue

CEO SUMMARY: When Avera Institute for Human Genetics wanted to expand its genomics program, it used its past learning with pharmacogenetics to guide the effort. Two key insights? Ask physicians abo…

Read More

---

Six Important Themes to Help Labs Succeed

By Scott Wallask | From the Volume XXX, No. 5 – March 27, 2023 Issue

CEO SUMMARY: Clinical laboratories face business challenges with day-to-day operations, genetic testing, and evolving care delivery models. The 2023 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management returns on April 25-26 in New Orleans. Participant…

Read More

---

Fujifilm Buys Inspirata’s Digital Pathology Assets

By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue

CEO SUMMARY: Fujifilm’s acquisition of the digital pathology technologies and clients of Inspirata marks the departure of one early entrant into the digital pathology market. At the same time, executives from Fujifilm Healthcare Americas Corporation discuss why the company is incr…

Read More

---

Atrium, Advocate Aurora Merge into $27b System

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

CEO SUMMARY: Integrated delivery networks continue to consolidate in the U.S., with the latest example being the merger of Atrium Health and Advocate Aurora Health. The deal forms a 67-hospital system across two distinct geographic areas in the Southeast and upper Midwest. IDN mergers raise the…

Read More

---

Innovation Showcased at Executive War College

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

CEO SUMMARY: This year’s Executive War College on Laboratory and Pathology Management proved to be a high-energy event. A record 900 attendees showed up and responded enthusiastically to visions and predictions of a post-COVID-19 healthcare system that hungers for large volumes of…

Read More

---